- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Pharma Companies Fund Antibiotic Start-Ups; COVID-19 Can Be Airborne; WHO Launches Pandemic Review
Twenty pharmaceutical companies created a $1 billion fund to aid financially strained antibiotic development start-ups; the World Health Organization (WHO) concedes that coronavirus disease 2019 (COVID-19) can become airborne; the WHO will launch an independent review into the global pandemic response after the United States formally withdrew from the organization.
Pharma Companies Offer Financial Aid to Start-Ups
Twenty pharmaceutical companies announced the creation of a $1 billion fund to bolster financially strapped biotech start-ups, The New York Times reports. The start-ups are working to develop new antibiotics to combat the increasing number of drug-resistant infections around the globe. The AMR Action Fund will be financed by Roche, Merck, and Johnson & Johnson and was created in partnership with the World Health Organization (WHO). Short-term lifelines will be offered to 2 dozen small antibiotic companies that have been struggling to gain investments. The number of antibiotics approved by the FDA for systemic use has largely decreased, from 61 approved between 1980 and 2009 to only 15 in the last decade.
COVID-19 Can Be Airborne, WHO Says
The WHO recently announced that coronavirus disease 2019 (COVID-19) can become airborne in indoor settings, but some experts felt the acknowledgement should have come sooner, according to The New York Times. The conclusion comes after over 200 scientists signed a letter urging the organization to revise its previous recommendations on the disease and its transmission. In an updated scientific brief, the organization noted the virus may linger in the air in crowded indoor spaces, and it also emphasized that the virus may be spread by asymptomatic individuals.
WHO Launches Independent Review Into Global Pandemic Response
The WHO will launch an independent review of the international response to the COVID-19 pandemic, STAT News reports. Helen Clarke, former prime minister of New Zealand, and Ellen Johnson Sirleaf, a Nobel Peace Prize winner and former Liberian president, will lead the review while countries can propose potential members for the independent panel. An interim report is expected to be published in November. The announcement comes after President Donald Trump formally notified the WHO that the United States will withdraw from the organization, criticizing its response to the pandemic.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
